Needham analyst Serge Belanger downgrades Tricida (NASDAQ:TCDA) from Buy to Hold.
Truist Securities Maintains Buy on HCA Healthcare, Raises Price Target to $290
Truist Securities analyst David Macdonald maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $270 to $290.